Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Third-line and Beyond Therapy”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07364422
What this trial is testing

To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer (GC)
Onconic Therapeutics Inc. 49
Testing effectiveness (Phase 2)Looking for participantsNCT06930118
What this trial is testing

The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.

Who this might be right for
Advanced Colorectal Cancer in the Third-line Treatment and BeyondpMMR/MSS Advanced Colorectal Cancer
Shanghai Changzheng Hospital 60
Large-scale testing (Phase 3)Study completedNCT01271712
What this trial is testing

Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Bayer 199
Testing effectiveness (Phase 2)UnknownNCT05266820
What this trial is testing

Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fujian Cancer Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06728852
What this trial is testing

Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)Recurrent or Metastatic Lung CancerThird-line and Beyond Therapy+1 more
Li-kun Chen 32
Testing effectiveness (Phase 2)Study completedNCT01860638
What this trial is testing

A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma

Who this might be right for
Glioblastoma
Hoffmann-La Roche 296
Large-scale testing (Phase 3)Not Yet RecruitingNCT07134205
What this trial is testing

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai JMT-Bio Inc. 252
Testing effectiveness (Phase 2)Looking for participantsNCT06895733
What this trial is testing

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

Who this might be right for
Solid Tumor, AdultNext-generation SequencingPrecision Medicine
Tianjin Medical University Second Hospital 65
Testing effectiveness (Phase 2)Looking for participantsNCT07085169
What this trial is testing

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

Who this might be right for
Colo-rectal CancerThird-line and Beyond TherapyTAS 102+1 more
Ruijin Hospital 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06343116
What this trial is testing

Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 420